Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Filamon LTD
PMV Pharmaceuticals, Inc
BeOne Medicines
Monte Rosa Therapeutics, Inc
ViroMissile, Inc.
AstraZeneca
AstraZeneca
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Eli Lilly and Company
Daiichi Sankyo
NanOlogy, LLC
Eli Lilly and Company
Oscotec Inc.
Adela, Inc
Second Life Therapeutics
Innate Pharma
Dysplasia Diagnostics Limited
Complement Theory Inc.
Tanabe Pharma America, Inc.
NeoTX Therapeutics Ltd.
NantCell, Inc.
DualityBio Inc.
Incyte Corporation
Pfizer
Hangzhou DAC Biotechnology Co., Ltd.
Novita Pharmaceuticals, Inc.
NextPoint Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
TransThera Sciences (Nanjing), Inc.
NGM Biopharmaceuticals, Inc
Sidekick Health
Merus B.V.
Tempus AI
Theratechnologies
Elevation Oncology
Seagen Inc.
Labcorp Corporation of America Holdings, Inc
Singlera Genomics Inc.
Oxford Vacmedix UK Ltd.
Agenus Inc.
Agenus Inc.
Carisma Therapeutics Inc
Pack Health
Zumutor Biologics Inc.
Travera Inc
Astellas Pharma Inc
Eli Lilly and Company
VitaMed Research LLC